Redox Signaling and Its Regulation in Cardiovascular Disease

Redox signaling, the process by which reactive oxygen species (ROS) and other redox-active molecules modulate cellular signaling pathways, plays a central role in the regulation of cardiovascular health. In the context of cardiovascular disease (CVD), dysregulated redox signaling contributes to various pathological processes, including inflammation, endothelial dysfunction, vascular remodeling, and myocardial injury. This review examines the role of redox signaling in CVD, focusing on the mechanisms through which ROS, particularly superoxide, hydrogen peroxide, and nitric oxide, influence cardiovascular function. We explore how ROS are involved in the activation of key signaling pathways, such as MAPK, NF-κB, and PI3K/Akt, which regulate processes critical to vascular homeostasis, including endothelial cell activation, smooth muscle cell proliferation, and extracellular matrix remodeling. The review also discusses the role of antioxidant defense systems in maintaining redox balance and preventing oxidative damage to cellular components. Furthermore, we examine the impact of redox signaling in specific cardiovascular conditions, including atherosclerosis, hypertension, heart failure, and ischemia-reperfusion injury. In particular, we highlight the dual role of ROS in both promoting vascular injury and serving as signaling molecules that mediate protective responses, such as endothelial nitric oxide production and ischemic preconditioning. We also discuss therapeutic approaches aimed at modulating redox signaling, including the use of antioxidants, redox-active compounds, and drugs that target redox-sensitive enzymes. Understanding the intricate balance between oxidative stress and redox signaling offers novel insights into the pathophysiology of cardiovascular diseases and provides promising therapeutic strategies for their prevention and treatment.